NCR3 and acute promyelocytic leukemia: Thus, in acute promyelocytic leukemia (APL), elevated tumor-derived prostaglandin-2 (PGD2) and B7H6 induce increases and hyperactivation of ILC2s through binding to CRTH2 and NKp30, respectively.